New Roche threat to Shire's hemophilia franchise? CEO Ornskov says he's not worried

13th December 2017 Uncategorised 0

Roche’s Genentech is out with a new threat to Shire’s hemophilia franchise in the form of a bispecific antibody dubbed Hemlibra—but the Dublin drugmaker’s CEO, for one, says he isn’t too concerned.

More: New Roche threat to Shire's hemophilia franchise? CEO Ornskov says he's not worried
Source: fierce